Mika Kauppala

Title: Mika Kauppala: Innovator in Pharmaceutical Compounds

Introduction

Mika Kauppala is a notable inventor based in Helsinki, Finland. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit catechol O-methyltransferase (COMT) activity. Her work has implications for various therapeutic applications.

Latest Patents

Mika Kauppala holds a patent for "Catechol O-methyltransferase activity inhibiting compounds." The compounds of formula (I), as defined in the claims, exhibit COMT enzyme inhibiting activity and are thus useful as COMT inhibitors. The patent also discloses methods of treatment and pharmaceutical dosage forms.

Career Highlights

Kauppala is associated with Orion Corporation, a prominent company in the pharmaceutical industry. Her role at Orion has allowed her to focus on innovative research and development in drug formulation and therapeutic solutions.

Collaborations

Mika has collaborated with notable colleagues, including Marko Ahlmark and David Din Belle. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Mika Kauppala's contributions to the field of pharmaceuticals through her innovative patents and collaborations highlight her role as a key inventor in the industry. Her work continues to pave the way for advancements in medical treatments.